Risk Evaluation and Legal Framework of the Nonsteroidal
Anti-inflammatory Drugs Around the World . . . . . . . . . . . . . . . . . . . . 321
Jesus Daniel Cardoso-Vera, Hariz Islas-Flores, Nely SanJuan-Reyes,
and Leobardo Manuel Go ´mez-Oliva ´n
Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 337
Leobardo Manuel Go ´mez-Oliva ´n
Contents
xiii